These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6004486)
21. [Cholestatic cirrhosis caused by lithiasic retention jaundice. Course of biliary and hepatic functions after operation]. Langeron P; Sigam M; Puppinck P Lille Med; 1971 Mar; 16(3):437-41. PubMed ID: 5566806 [No Abstract] [Full Text] [Related]
22. [The glucuronide pattern after peroral dosage with acetanilide in chronic hepatitis and liver cirrhosis]. Hammar CH; Prellwitz W Klin Wochenschr; 1966 Sep; 44(17):1010-4. PubMed ID: 5993592 [No Abstract] [Full Text] [Related]
23. [Methods and clinical value of the wofaverdin test within the limits of the chromodiagnosis of the liver]. Seifert A; Ehrke D; Balzer H Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):185-7. PubMed ID: 5732394 [No Abstract] [Full Text] [Related]
24. The urinary excretion of glucosiduronates of cortisol and cortisone. Luttrell BM; Steinbeck AW J Clin Endocrinol Metab; 1976 Mar; 42(3):567-74. PubMed ID: 176171 [TBL] [Abstract][Full Text] [Related]
25. Reduced hepatic functional reserve in cirrhosis and obstructive jaundice with special reference to histological morphometric analysis and galactose elimination capacity. Kaiho T; Miyazaki M; Ito H; Ambiru S; Shimizu H; Togawa A; Ohtsuka M; Shiobara M; Shimizu Y; Sasada K; Yoshioka S; Yoshidome H; Nakajima N Eur Surg Res; 1996; 28(5):333-40. PubMed ID: 8880122 [TBL] [Abstract][Full Text] [Related]
26. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver]. Loginov AS; Aruin LI; Shepeleva SD Arkh Patol; 1980; 42(4):50-5. PubMed ID: 7396755 [TBL] [Abstract][Full Text] [Related]
27. Disturbances of bile acid metabolism in cholestasis. Stiehl A Clin Gastroenterol; 1977 Jan; 6(1):45-67. PubMed ID: 330052 [No Abstract] [Full Text] [Related]
28. [A case of neonatal galactosemia]. Savasteeva NV; Dobroskokova NF; Zhukova VA; Nadeev AP; Aksenova VP; Travin MA Arkh Patol; 2010; 72(1):41-2. PubMed ID: 20369586 [TBL] [Abstract][Full Text] [Related]
29. [Absorption of triolein-I 131 and oleic acid- I 131 in hepatic diseases (obstructive jaundice, cirrhosis, steatosis and cancer of the liver]. Afifi F; Boivin P Rev Int Hepatol; 1967; 17(5):411-21. PubMed ID: 6056142 [No Abstract] [Full Text] [Related]
30. [Renal clearance of the glucuronized fractions of bilirubin in various types of jaundice. V. Jaundice caused by tumoral hepatopathies]. Candel Monserrate I; Díaz-Rubio García M; de Damborenea Y Glez de Landeta D; Carballo Alvarez LF Rev Esp Enferm Apar Dig; 1975 Nov; 46(5):485-98. PubMed ID: 172987 [No Abstract] [Full Text] [Related]
31. Hepatic detoxification and hepatic function in chronic active hepatitis with and without cirrhosis. Müting D; Kalk JF; Fischer R; Wuzel H; Reikowski J Dig Dis Sci; 1988 Jan; 33(1):41-6. PubMed ID: 3123178 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of liver function by means of the glucagon test]. Brunner H; Grabner G; Michalek P; Paumgartner G Wien Z Inn Med; 1968; 49(11):409-17. PubMed ID: 5737590 [No Abstract] [Full Text] [Related]
33. [Renal clearance of glucuronized fractions and bilirubin in various forms of jaundice. VI. Obstructive jaundice]. Candel Monserrate I; Díaz-Rubio García M; De Damborenea LE; De Landeta G Rev Esp Enferm Apar Dig; 1975 Dec; 46(6):615-30. PubMed ID: 813282 [No Abstract] [Full Text] [Related]